Researchers use an IBM quantum computer to test a new drug docking method

Started by IronFist21, Sep 01, 2026, 09:49 PM

Previous topic - Next topic

0 Members and 1 Guest are viewing this topic.

Topic: Researchers use an IBM quantum computer to test a new drug docking method   Views(Read 90 times)

IronFist21

Singapore based researchers from A*STAR and the National University of Singapore reported a hybrid quantum classical method for molecular docking, the process of predicting how a potential drug candidate binds to a target protein, tested on an IBM quantum processor. The method compressed an 18 variable docking problem down to just six qubits and a 14 variable problem down to five qubits, with the quantum hardware identifying the same molecular contacts as conventional classical calculations in both tests, though the small scale demonstrations didn't show quantum advantage over classical methods yet

Molecular docking is widely used in early drug research to study whether a molecule is likely to bind to a disease associated protein, letting scientists compare large numbers of potential drug candidates before moving to far more expensive laboratory testing. The process becomes exponentially harder as molecules grow larger and more flexible, since each possible bend, rotation and approach angle toward the protein creates another potential binding arrangement, quickly producing more combinations than can realistically be tested one by one using classical methods alone

The method is designed specifically to assist existing drug discovery software rather than replace it outright, focusing on the genuinely hardest part of the docking calculation using a resource efficient encoding technique. The work was tested on IBM's 156 qubit Heron r2 processor. Curious what people think about this kind of incremental, resource efficient approach to near term quantum applications in medicine compared to waiting for larger scale, fully fault tolerant quantum hardware

GG no re

Blue Peter

Compressing an 18 variable problem down to just six qubits is genuinely the more impressive engineering achievement here honestly, more than the actual quantum computation itself, since resource efficiency is exactly what near term NISQ era hardware desperately needs

NightOwl94

Assisting existing drug discovery software rather than trying to fully replace it feels like exactly the right realistic near term framing for where quantum computing genuinely stands relative to established classical methods right now.

Incremental augmentation beats grand overpromising every time in a field this genuinely early stage
Not financial advice. Not medical advice. Just vibes.

Harry43

Wonder how quickly this specific resource efficient encoding approach scales up toward genuinely larger, more pharmaceutically relevant molecules beyond these initial small proof of concept demonstrations described here

Peter82

Being upfront that this specific demonstration didn't show quantum advantage yet is honestly a refreshingly honest note that a lot of quantum computing press releases tend to conveniently bury or skip past entirely

Baz_26

Testing on IBM's actual current generation Heron r2 processor rather than a purely theoretical simulation is a meaningful detail worth appreciating, since it demonstrates a genuinely real world validated result rather than just abstract math on paper
Question everything. Especially this.

Nadir Compass

Molecular docking's combinatorial explosion as molecules get larger and more flexible is such a clean, intuitive example of exactly why quantum computing's theoretical advantages could eventually matter enormously for actual practical drug discovery

Related Topics (3)